DEANA FREEMAN: Open Payments
NPI 1225498447 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 69 payments from 20 companies in 2025. Trend: 2023 $332 · 2024 $216 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $369 |
| GlaxoSmithKline, LLC. | 5 | $77 |
| ViiV Healthcare Company | 3 | $72 |
| Dexcom, Inc. | 3 | $59 |
| Abbott Laboratories | 3 | $57 |
| Lilly USA, LLC | 3 | $44 |
| Amgen Inc. | 3 | $43 |
| Exact Sciences Corporation | 2 | $34 |
| SHIELD THERAPEUTICS INC | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
Products named: VRAYLAR, UBRELVY, APRETUDE, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, CREON, SHINGRIX, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
